Рет қаралды 49,733
Join the U.S. Food and Drug Administration for an upcoming meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) to discuss considerations for future COVID-19 vaccine booster doses and the process for selecting specific strains of the SARS-CoV-2 virus for COVID-19 vaccines to address current and emerging variants.